ALLAKOS INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
ALLAKOS INC. - More news...
ALLAKOS INC. - More news...
- Allakos Announces Positive Phase 1 Results with AK002 in Indolent Systemic Mastocytosis
- Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts
- Allakos to Host Investor Day on February 19 in New York City
- Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism
- Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-Naïve Chronic Spontaneous Urticaria Patients
- Allakos Announces Clinical Update and Third Quarter 2018 Financial Results
- Allakos Presents Data from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting